Sign in

CCM on NYSE

Concord Medical Services Holdings Ltd

Concord Medical Services Holdings Ltd is an offices and Clinics of Doctors of Medicine services company.1 Its shares trade on NYSE under the symbol CCM.1

Price unavailable

Last updated Oct 21, 2026.

Overview

$65.0MRevenue, fiscal 20252
-$13.3MNet income, fiscal 20252

Compare with Airsculpt Technologies, Inc., SBC Medical Group Holdings Inc or LifeMD, Inc., or pick any stock.

  • TickerCCM on NYSE1
  • IndustryServices-Offices & Clinics of Doctors of Medicine1
  • HeadquartersE91
  • Incorporated inCayman Islands3
  • Business addressRoom 26A1-26A5, East Tower, Hanwei, Building No. 7 Guanghua Road, Chaoyang District, Beijing, 1000203
  • Filer categoryNon-accelerated filer3

See how the biggest companies compare on our leaderboards

Concord Medical Services Holdings Limited (“Concord Medical”) was incorporated in the Cayman Islands on November 27, 2007 as a limited liability company. Concord Medical became our ultimate holding company on March 7, 2008, when the shareholders of Ascendium Group Limited (“Ascendium”), a holding company incorporated in the British Virgin Islands on September 10, 2007, exchanged all of their shares of Ascendium for shares of Concord Medical. Prior to that, on October 30, 2007, Ascendium had acquired 100% of the equity interests in Our Medical Services, Ltd. (“OMS”), resulting in a change in control. We refer to this transaction as the OMS reorganization in this annual report. Prior to the OMS reorganization, OMS, together with Shenzhen Aohua Medical Service Co., Ltd. (“Aohua Medical”), in which OMS effectively held all of the equity interests at the time, operated all of our business.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

5.7%Gross margin2
-57.6%Operating margin2
-20.4%Net margin2
26.6%Revenue growth, 20252
-$36.9MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue96¢$62.2M
  • Other costs3¢$1.9M
  • Income tax1¢$867.0K

Out of $65.0M in revenue.2 The company lost money this year.

Financial statements

Revenue5678910112$65.0M in 2025+134% since 2018
0$20.0M$40.0M$60.0M$80.0M2018: $27.8M$27.8M20182019: $20.1M$20.1M2019−28%2020: $26.1M$26.1M2020+30%2021: $69.5M$69.5M2021+167%2022: $65.3M$65.3M2022−6%2023: $73.3M$73.3M2023+12%2024: $51.3M$51.3M2024−30%2025: $65.0M$65.0M2025+27%
Gross profit5678910112$3.7M in 2025+28% since 2018
-$30.0M-$20.0M-$10.0M0$10.0M2018: $2.9M$2.9M20182019: -$2.3M-$2.3M20192020: $2.0M$2.0M20202021: -$8.9M-$8.9M20212022: -$22.1M-$22.1M2022+147%2023: -$10.8M-$10.8M2023−51%2024: -$10.8M-$10.8M2024+1%2025: $3.7M$3.7M2025
Operating income5678910112-$37.4M in 2025−14% since 2018
-$80.0M-$60.0M-$40.0M-$20.0M02018: -$43.5M-$43.5M20182019: -$62.8M-$62.8M2019+44%2020: -$48.4M-$48.4M2020−23%2021: -$71.9M-$71.9M2021+49%2022: -$76.1M-$76.1M2022+6%2023: -$65.2M-$65.2M2023−14%2024: -$72.9M-$72.9M2024+12%2025: -$37.4M-$37.4M2025−49%
Net income5678910112-$13.3M in 2025−61% since 2018
-$80.0M-$60.0M-$40.0M-$20.0M02018: -$34.2M-$34.2M20182019: -$44.1M-$44.1M2019+29%2020: -$47.5M-$47.5M2020+8%2021: -$42.6M-$42.6M2021−10%2022: -$71.0M-$71.0M2022+67%2023: -$41.9M-$41.9M2023−41%2024: -$42.2M-$42.2M2024+1%2025: -$13.3M-$13.3M2025−69%
Fiscal year20182019202020212022202320242025
Revenue$27.8M5$20.1M6$26.1M7$69.5M8$65.3M9$73.3M10$51.3M11$65.0M2
Cost of revenue$24.9M5$30.8M6$32.2M7$85.1M8$90.5M9$86.5M10$63.4M11$62.2M2
Gross profit$2.9M5-$2.3M6$2.0M7-$8.9M8-$22.1M9-$10.8M10-$10.8M11$3.7M2
Operating income-$43.5M5-$62.8M6-$48.4M7-$71.9M8-$76.1M9-$65.2M10-$72.9M11-$37.4M2
Interest$6.7M5$4.1M6$12.5M7$11.6M8$17.4M9$23.3M10
Income before tax$83.0M8$121.8M9$78.3M10-$91.7M11-$53.4M2
Income tax$5.0M5-$5.6M6-$5.8M7-$1.0M8-$10.3M9-$3.5M10-$2.4M11$867.0K2
Net income-$34.2M5-$44.1M6-$47.5M7-$42.6M8-$71.0M9-$41.9M10-$42.2M11-$13.3M2
Earnings per share-$0.549-$0.3210-$0.3211-$0.102
Earnings per share (diluted)-$0.549-$0.3210-$0.3211-$0.102
Shares (weighted, basic)131.1M shares10131.1M shares11131.1M shares2131.1M shares2131.1M shares2
Shares (weighted, diluted)131.1M shares10131.1M shares11131.1M shares2131.1M shares2131.1M shares2

Compare Concord Medical Services Holdings Ltd with another company

What it owns

What Concord Medical Services Holdings Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$603.9M2 Dec 31, 2025$562.6M11 Dec 31, 2024+7.3%
Accumulated depreciation$70.2M2 Dec 31, 2025$54.0M11 Dec 31, 2024+29.9%
Property and equipment, net$532.6M2 Dec 31, 2025$507.5M11 Dec 31, 2024+5.0%
Operating-lease assets (leased space)$71.0M2 Dec 31, 2025$71.4M11 Dec 31, 2024−0.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$42.6M2 Dec 31, 2025$29.6M11 Dec 31, 2024+43.7%
Marketable securities, current$18.4M11 Dec 31, 2024$06 Dec 31, 2019
Debt securities available for sale$02 Dec 31, 2025$2.0M11 Dec 31, 2024−100.0%
Stakes in other companies (equity method)$59.4M2 Dec 31, 2025$58.8M11 Dec 31, 2024+1.1%
Long-term investments$60.3M2 Dec 31, 2025$64.7M11 Dec 31, 2024−6.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$81.8M2 Dec 31, 2025$81.8M2 Dec 31, 20240%
Intangible assets, net (excluding goodwill)$36.6M2 Dec 31, 2025$40.0M11 Dec 31, 2024−8.6%
Finite-lived intangibles, gross486.2M CNY2 Dec 31, 2025489.5M CNY11 Dec 31, 2024−0.7%
Accumulated amortization229.4M CNY2 Dec 31, 2025196.4M CNY11 Dec 31, 2024+16.8%
Finite-lived intangibles, net$36.6M2 Dec 31, 2025$40.0M11 Dec 31, 2024−8.6%

Inventory

ItemLatestA year beforeChange
Inventory, total$6.6M2 Dec 31, 2025$4.6M11 Dec 31, 2024+43.5%

Leadership

Who has led Concord Medical Services Holdings Ltd, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Jianyu Yang2026–now

Chief financial officer

  1. Botao Shi2026–now
Board members and other officers (3)

Timeline

  1. Mar 18, 2026New chief executive Jianyu Yang becomes CEO12

Filings

66 filings to the SEC since October 2021: 6 annual reports, 7 insider forms, 53 other. The latest 20:

  1. Sep 22, 20266-K EDGAR
  2. Jul 9, 20263 OWNERSHIP DOCUMENT EDGAR
  3. Jul 2, 20266-K EDGAR
  4. May 18, 20266-K EDGAR
  5. May 13, 20266-K EDGAR
  6. May 13, 20266-K EDGAR
  7. Apr 29, 202620-F EDGAR
  8. Apr 15, 20266-K EDGAR
  9. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR
  10. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR
  11. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR
  12. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR
  13. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR
  14. Mar 18, 20263 OWNERSHIP DOCUMENT EDGAR
  15. Dec 2, 20256-K EDGAR
  16. Sep 30, 20256-K EDGAR
  17. Sep 26, 20256-K EDGAR
  18. Aug 28, 20256-K EDGAR
  19. Jul 29, 20256-K EDGAR
  20. Jul 22, 20256-K EDGAR

The 66 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
SmartHarvest Portfolios, LLC13,912$65.7K0.0%New
Susquehanna International Group, Llp11,069$52.2K0.0%−654
Citadel Advisors LLC10,543$49.8K0.0%New
UBS Group AG500$2.4K0.0%−115
Morgan Stanley100$4720.0%No change
Jones Financial Companies Lllp10$470.0%New
SBI Securities Co., Ltd.4$190.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Concord Medical Services Holdings Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARConcord Medical Services Holdings Ltd1
  • CIK0001472072
  • Filer statusNon-accelerated filer not an emerging growth company; not a shell company4
  • Incorporated inCayman Islands4
  • Industry code (SIC)8011 Services-Offices & Clinics of Doctors of Medicine1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressRoom 26A1-26A5, East Tower, Hanwei, Building No. 7 Guanghua Road, Chaoyang District, Beijing, 100020, China1
  • Phone(86)10-5825-68671
  • Shares outstanding130,251,685 shares; 84,463,737 Common Class A shares; 45,787,948 Common Class B shares as of Dec 31, 20254
  • AuditorShandong Haoxin Certified Public Accountants Co., Ltd., Weifang, People’s Republic of China PCAOB ID 5035; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceNov 17, 20091
  • Filings215 in all: 6-K (129), 20-F (17), SC 13G/A (9), SC 13D/A (8), 3 (7), UPLOAD (7), SC 13G (6), F-1/A (5)1
    All 25 form types

    CORRESP (4), 6-K/A (3), SC 13D (3), 20-F/A (2), EFFECT (2), F-6 POS (2), 424B4 (1), 8-A12B (1), CERTNYS (1), CT ORDER (1), F-1 (1), F-6 (1), FWP (1), NT 20-F (1), S-8 (1), SC 13E3 (1), SC 13E3/A (1)

  • Latest filingsAnnual report (20-F) Apr 29, 2026

Securities registered for trading

ClassSymbolExchange
American depositary shares, each representing 30 Class A ordinary shares, par value US$0.0001 per shareCCMNew York Stock Exchange
Class A ordinary shares, par value US$0.0001 per shareNYSE

From the cover page of the 20-F filed Apr 29, 2026 (Section 12(b) of the Exchange Act).4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15